Record Revenue Milestones
Q4 2025 revenues increased 11% to $2.149 billion (first quarterly result > $2.0B). Full year 2025 revenues rose 16% to $7.939 billion from $6.828 billion in 2024.
Strong Segment Growth
Q4 segment performance: C4I & Cyber +19% (driven by radios and C2 systems), ISTAR & EW +39% (maritime and electro-optic, EW and counter-UAS), Land +22% (ammunition/munitions sales), Elbit Systems of America +9%; Aerospace declined -14%.
Expanded Profitability and Margins
GAAP operating income Q4 $192M (9.0% of revenues) vs $141M (7.3% prior year). Non-GAAP operating income Q4 $210M (9.8%) vs $157M (8.2%). Full year non-GAAP operating income $737M (9.3%) vs $550M (8.1%). Gross margins improved: GAAP Q4 24.7% vs 24.1%; non-GAAP Q4 25.0% vs 24.5%.
Significant EPS Expansion
GAAP diluted EPS Q4 $3.52 vs $2.00 prior-year quarter; non-GAAP diluted EPS Q4 $3.56 vs $2.66. Full year GAAP EPS $11.39 vs $7.18 and non-GAAP EPS $12.75 vs $8.76.
Record Backlog and International Diversification
Backlog grew to $28.1 billion, up ~$5.5 billion year-over-year (~24% YoY backlog growth). Approximately 72% of backlog from outside Israel; 54% of backlog scheduled for 2026-2027.
Material Free Cash Flow and Operating Cash Generation
Net cash from operating activities $778M in 2025 vs $535M in 2024. Free cash flow delivered $553M, up 73% from $320M in 2024.
Major Contract Wins and Technology Milestones
Secured IMOD contracts for airborne high-power laser fighter pod and helicopter solutions; won largest-ever international strategic contract (~$2.3B) and an earlier $1.6B European award. PULS launcher backlog exceeded $2B; multiple EW, DIRCM and Active Protection (Iron Fist) wins including NATO CV90 and U.S. Army Bradley follow-ons.
Capital Allocation and Dividend Increase
Board declared a $1.00 per share dividend (increase). Company invested $225M CapEx in 2025 and plans ~ $300M CapEx in 2026 to expand capacity; sustained R&D investment with net R&D expenses $517M (6.5% of revenues).
Improving Financial Efficiency
Financial expenses decreased to $138M in 2025 from $151M in 2024 (lower interest and debt). Effective tax rate declined to 9.9% from 11.4% due to valuation allowance releases and tax settlements.